scorecardresearch
Business Today
Subscribe
Immersives UPSTART ICC World Cup Corporate Petrol-Diesel Weather BT Bazaar
BT Golf BT 500 Zero Mile Samvad - IIM Nagpur BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Bharat Immunological & Biological Corporation Ltd

Feedback
Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 31,893
Dec 15, 2023 10:29 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹26.99
₹0.52 (1.96%)
    Powered By :
₹26.7 Low
Today’s Performance
₹27.4 High
₹20.5 Low
52 Week’s Performance
₹51.8 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 1.96%
  • 1 Week 1.30%
  • 1 Month 9.29%
  • 3 Months 5.42%
  • 6 Months 14.49%
  • 1 Year -4.96%
  • 3 Years -13.29%
  • 5 Years 17.40%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.06
  • 52-Week Low (₹) 20.50
  • 52-Week High (₹) 51.80
  • Price-to-Book (X)* -3.51
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 0.00
  • Earnings Per Share (₹) 0.00
  • Sector Price Earning (X)* 32.73
  • Market Cap (₹ Cr.)* 114.30
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 1:59 Sudeep Shah From SBI Securities Identifies Two Stocks Poised For Strong Upside Movement!
thumb 3:29 Shri Krishna Janmabhoomi Case: High Court Approves Survey Of Shahi Idgah Complex
thumb 2:07 Listen To SMIFS' Sharad Avasthi's Call On DOMS & India Shelter Finance IPOs Ending On Friday
thumb 2:09 Electrifying Delhi's Commute: Delhi's Got More Electric Buses! Hop On Board For A Greener Commute!
thumb 3:59 Derek O'Brien Suspended After Face-off With RS Chairman! MP Charged With "Ignoble Misconduct"
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Dec 23, 2022 PURCHASE
BIBCL ,TOPGAIN FINANCE PRIVATE LIMITED
  • Qty 220559
  • Average Price ₹44.12
Dec 23, 2022 Sell
BIBCL ,TOPGAIN FINANCE PRIVATE LIMITED
  • Qty 220559
  • Average Price ₹44.85
Dec 27, 2022 Sell
BIBCL ,MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED
  • Qty 340168
  • Average Price ₹44.49
Dec 27, 2022 PURCHASE
BIBCL ,MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED
  • Qty 497590
  • Average Price ₹44.50
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Bharat Immunological & Biological Corporation Ltd share price previously?
Bharat Immunological & Biological Corporation Ltd share price was up by 1.96% from the previous closing price of ₹26.47.
Who are peers of Bharat Immunological & Biological Corporation Ltd?
The peers of Bharat Immunological & Biological Corporation Ltd are Syngene International Ltd, Zydus Lifesciences Ltd, Cipla Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd, Ipca Laboratories Ltd, Lupin Ltd, Gland Pharma Ltd, Glaxosmithkline Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Torrent Pharmaceuticals Ltd, Divis Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Biocon Ltd.
Who is/are the promoter/promoters of Bharat Immunological & Biological Corporation Ltd?
The promotor/promotors of Bharat Immunological & Biological Corporation Ltd are Y K Gupta, Sandip K Lal, Alka Sharma, Mohd Aslam, Sudhanshu Vrati, Madhu Dikshit, Sanjay Kumar Mishra, Pankaj Kumar.
What has been 52-week high of Bharat Immunological & Biological Corporation Ltd stocks?
The highest price of Bharat Immunological & Biological Corporation Ltd stock is ₹51.80 in the last 52-week.
What is the share price of Bharat Immunological & Biological Corporation Ltd () today on BSE?
As on Dec 15, 2023, Bharat Immunological & Biological Corporation Ltd ()’s share price on BSE is Rs 26.99
What is the market cap of Bharat Immunological & Biological Corporation Ltd (?)
The current market capitalisation of Bharat Immunological & Biological Corporation Ltd () is 114.30 crores
What is Bharat Immunological & Biological Corporation Ltd Share symbol?
The symbol of Bharat Immunological & Biological Corporation Ltd is .
What is the PE ratio of Bharat Immunological & Biological Corporation Ltd ()?
The current PE ratio of Bharat Immunological & Biological Corporation Ltd () is 0.00.
What is the PB ratio of Bharat Immunological & Biological Corporation Ltd ()?
The current PB ratio of Bharat Immunological & Biological Corporation Ltd () is -3.51.
Today’s High & Low share prices of Bharat Immunological & Biological Corporation Ltd () on BSE?
Today, the share price of Bharat Immunological & Biological Corporation Ltd () on BSE touched a high of Rs 27.4 and a low of Rs 26.7
What price did Bharat Immunological & Biological Corporation Ltd () shares open on the BSE today?
On BSE, the share price of Bharat Immunological & Biological Corporation Ltd () opened at Rs 26.7
What is the 52-week high of Bharat Immunological & Biological Corporation Ltd ()?
The 52-week high price of Bharat Immunological & Biological Corporation Ltd () is Rs 51.8
What is the 52-week low of Bharat Immunological & Biological Corporation Ltd () ?
The 52-week low price of Bharat Immunological & Biological Corporation Ltd () is Rs 20.5

ABOUT BHARAT IMMUNOLOG

Bharat Immunological & Biological Corporation Ltd, incorporated in the year 1989, has its registered office in BIBCOL OPV Plant Village Chola, Bulandshahr, Uttar Pradesh, 203203, 91-5732-238210. The main industry in which Bharat Immunological & Biological Corporation Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Bharat Immunological & Biological Corporation Ltd is/are Reshma & Co. In the main management, Y K Gupta is chairman and Sandip K Lal is the company secretary for Bharat Immunological & Biological Corporation Ltd.

  • YKG Y K Gupta Chairman & Independent Directo
  • SKL Sandip K Lal Company Sec. & Compli. Officer
  • AS Alka Sharma Independent Director
  • MA Mohd Aslam Independent Director
  • SV Sudhanshu Vrati Independent Director
  • MD Madhu Dikshit Independent Director
  • SKM Sanjay Kumar Mishra Managing Director
  • PK Pankaj Kumar Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement